Coronavirus disease 2019 (COVID-19) is defined as illness caused by a novel coronavirus now called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2; formerly called 2019-nCoV), which was first identified amid an outbreak of respiratory illness cases in Wuhan City, Hubei Province, China. It was initially reported to the WHO on December 31, 2019. On January 30, 2020, the WHO declared the COVID-19 outbreak a global health emergency. On March 11, 2020, the WHO declared COVID-19 a global pandemic, its first such designation since declaring H1N1 influenza a pandemic in 2009.
Programs established by the FDA allowing clinicians to gain access to investigational therapies during the pandemic have been essential. The expanded access (EA) and emergency use authorization (EUA) programs allowed for rapid deployment of potential therapies for investigation and investigational therapies with emerging evidence. A review by Rizk et al describes the role for each of these measures and their importance of providing medical countermeasures in the event of infectious disease and other threats.
COVID-19 EUAs
The antiviral drug, remdesivir (Veklury) and the mRNA COVID-19 vaccine (Comirnaty) have gained full approval from the FDA. However, certain indications and use in specific populations for each of these therapies remain within their EUAs.
EUA facts sheets for clinicians are available to provide detailed information regarding drugs, biologicals, and vaccines that have been issued an EUA as a COVID-19 therapy or prevention.
Remdesivir
Full FDA approval: Remdesivir is indicated for adults and pediatric patients aged 12 years and older (weighing at least 40 kg) for treatment of COVID-19 that requires hospitalization
EUA: Treatment of COVID-19 in hospitalized pediatric patients weighing 3.5 kg to less than 40 kg or hospitalized pediatric patients younger than 12 years weighing at least 3.5 kg
Tocilizumab
EUA: Tocilizumab’s EUA is for the treatment of hospitalized adults and pediatric patients (aged 2 years and older) with COVID-19 who are receiving systemic corticosteroids and require supplemental oxygen, noninvasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ECMO).
Baricitinib
EUA: The baricitinib EUA is for treatment of suspected or laboratory-confirmed coronavirus disease 2019 (COVID-19) in hospitalized patients aged 2 years and older who require supplemental oxygen, invasive mechanical ventilation, or extracorporeal membrane oxygenation (ECMO).
Remdesivir
Several phase 3 clinical trials have tested remdesivir for treatment of COVID-19 in the United States, South Korea, and China. Positive results were seen with remdesivir after use by the University of Washington in the first case of COVID-19 documented on US soil in January 2020. An adaptive randomized trial of remdesivir coordinated by the National Institute of Health (NCT04280705) was started first against placebo, but additional therapies have been added to the protocol as evidence emerges. The first experience with this study involved passengers of the Diamond Princess cruise ship in quarantine at the University of Nebraska Medical Center in February 2020 after returning to the United States from Japan following an on-board outbreak of COVID-19. Trials of remdesivir for moderate and severe COVID-19 compared with standard of care and varying treatment durations are ongoing.
An EUA for molnupiravir was requested in October 2021. The FDA’s Antimicrobial Drugs Advisory Committee narrowly voted to recommend the FDA authorize molnupiravir for EUA on November 30, 2021.
Molnupiravir (MK-4482 [previously EIDD-2801]; Merck and Ridgeback Biotherapeutics) is an oral antiviral agent that is a prodrug of the nucleoside derivative N4-hydroxycytidine. It elicits antiviral effects by introducing copying errors during viral RNA replication of the SARS-CoV-2 virus.
The phase 3 MOVe-OUT study (n = 1433) found molnupiravir reduced risk of hospitalization or death from 9.7% (68 of 699) in the placebo group to 6.8% (48 of 709) in the molnupiravir group for an absolute risk reduction of 3% (p = 0.02) and a relative risk reduction of 30%. Nine deaths were reported in the placebo group and 1 in the molnupiravir group. These data are consistent with the interim analysis.
Molnupiravir is also being evaluated in a phase 3 trial for postexposure prophylaxis for individuals residing in the same household with someone who tests positive for SARS-CoV-2 in the phase 3 MOVE-AHEAD trial.
An EUA for molnupiravir was requested in October 2021. The FDA’s Antimicrobial Drugs Advisory Committee is scheduled to discuss the request November 30, 2021.
Favipiravir (Avigan, Reeqonus; Appili Therapeutics) is an oral antiviral that disrupts viral replication by selectively inhibiting RNA polymerase. An adaptive, multicenter, open label, randomized, phase 2/3 clinical trial of favipiravir compared with standard of care I hospitalized patients with moderate COVID-19 was conducted in Russia. Both dosing regimens of favipiravir demonstrated similar virologic response. Viral clearance on Day 5 was achieved in 25/40 (62.5%) patients on in the favipiravir group compared with 6/20 (30%) patients in the standard care group (p = 0.018). Viral clearance on Day 10 was achieved in 37/40 (92.5%) patients taking favipiravir compared with 16/20 (80%) in the standard care group (p = 0.155).
The phase 3 PRESECO (PREventing SEvere COVID-19) study evaluated early treatment in patients with mild-to-moderate symptoms to prevent disease progression and hospitalization. Entrollment was completed in September 2021. The phase 3 PEPCO (Post Exposure Prophylaxis for COVID-19) study in asymptomatic individuals with direct exposure (within 72 hours) to an infected individual is ongoing.
Discover more from Dr AM Thirugnanam
Subscribe to get the latest posts sent to your email.
I am rеaⅼly imрressed together witһ your writing talents and also with the structure to уour weblog.
Is tһis a paid subject or did you customize it yourself?
Either wɑy keep up the еxcellent high quality writing, it’s
гare to peer a great blog like this one nowadays..
Myself writing all the articles in this website. thank your valuable comment.
Тhis design is spectacular! You most certainly know how to kеep a reader entertaineɗ.
Between your wit and your videos, I was almost moved to ѕtart my own blοg (well,
almost…HaHa!) Great job. I really loved what you had tߋ say, and more
than that, how you presented it. Too cooⅼ!
ToԀay, Ӏ ᴡent to the beach with my children. I found a sea shell
and gave it to my 4 year old daughter and said “You can hear the ocean if you put this to your ear.” She
put the shell to her ear and screamed. There was a hermit
crab inside and it pinched hеr ear. She never wants to
go back! LoL I know this is totally off topic ƅut I had to tell
someone!
I’ⅼl rіght away grasp your rss as I can’t
in finding your e-mail subscription link or newsletter
service. Do yoᥙ’ve any? Please permit me realize in order
that I could subscribe. Tһanks.
Wondеrful beat ! I wish to apprentice whiⅼe you amｅnd
your website, һow can i subscrіbe for a blog site?
Tһe ɑcⅽount helped me a acceptable deal. I had been tiny bit acquainted of this үour broadcast
offeгed bright clear concept
I’ve beеn exploring for a bit for any һigh-quality articles or weblog pⲟѕts on this kind of area .
Explorіng in Yahoo I at last stumbled uρon this webѕite.
Reading this info So i’m happy to eⲭhibit that I have
an incredibly just right uncanny feeling I discovered
exactly what I needed. I such ɑ lot certainly wilⅼ
make certain to do not overloоk this ᴡebsitе and ɡive it
a look on a continuing basis.
Unqսestionably imagine that that y᧐u stateⅾ. Your favourite reason appeared tо be at tһe web the easiest factor to remеmber of.
I say to you, I definitely get annoyed even as other
people think about worriеs that they just don’t understand abօut.
You controlled to һit the nail upon the top
and oսtlined out thе entirе thing without having side-еffects ,
other people can take a signal. Will likely be back to get more.
Thanks
I wɑs recommеnded this website by my cousin. I am not sure whether this post is written by
hіm as nobody еlse қnow such detailed about my pr᧐blem.
Yоu are amɑzing! Thanks!
порно фото проституток https://sexs-foto.xyz/ голые толстые девушки
секс видео мжм
юная сосалка на съемках в порно
секс с мужчиной видео
порно видео красивый секс
секс видео изменила мужу
порно видео ебли баб
ебле раком
любительская ебля
уникальные сосалки порно
секс порно видео 2022
0f9c1e0
Have you ever thouɡht about inclᥙding a little bit moｒe
than just your articles? I mean, whаt you say is fundamental
and all. But imagine if you added some great visuals or vidеos to gіve yоur ρosts more, “pop”!
Your cօntent is excellent but with pіcs and vidеos, thiѕ site could certainly be one of the most beneficial in its field.
Teгrific blog!
The very core of your writing whilst sounding reasonable originally, did not really work perfectly with me after some time. Someplace throughout the paragraphs you actually were able to make me a believer unfortunately only for a very short while. I still have a problem with your leaps in assumptions and one would do nicely to fill in all those breaks. If you can accomplish that, I will surely end up being impressed.
I’d perpetually want to be update on new blog posts on this internet site, saved to fav! .
Hi, Neat post. There’s a problem with your site in internet explorer, would check this… IE still is the market leader and a large portion of people will miss your excellent writing due to this problem.
Awesome! Its in fact amazing post, I have got much clear idea regarding from this piece of
writing.
I really love your site.. Excellent colors & theme. Did you make this web site
yourself? Please reply back as I’m trying to create my own personal
site and want to find out where you got this from or just what the theme is named.
Thanks!
professional created this, Thanks for your comment
Hi there, I think your blog could possibly be having web browser compatibility problems. Whenever I take a look at your site in Safari, it looks fine however, when opening in IE, it has some overlapping issues. I simply wanted to give you a quick heads up! Other than that, great site!
Howdy! This blog post couldn’t be written much better! Reading through this article reminds me of my previous roommate! He constantly kept talking about this. I am going to send this post to him. Pretty sure he’s going to have a great read. I appreciate you for sharing!
very interesting, but nothing sensible
_________________
ойын автоматтарын
interesting news
_________________
rcbc-те жалдауға арналған онлайн-казинолық дилері
don’t think anything
_________________
нақты ақша жанартау казинолық үшін онлайн ойын автоматтары
interesting news
_________________
ойын автоматтарын
Your article gave me a lot of inspiration, I hope you can explain your point of view in more detail, because I have some doubts, thank you.
Hi friends, its fantastic article about educationand fully explained, keep it up all the time.
Really helpful read, thank you. As someone working in hotel and management, this article really caught my attention.
For anyone interested in hotel guest services, hotel booking process, or learning more about hotel front office operations and customer service, I highly recommend a helpful book I found recently on Amazon. It’s full of practical hotel English conversation examples, hotel receptionist English phrases, and hotel check-in dialogue in English that are useful for both beginners and professionals.
It’s especially helpful for those studying a bachelor of hospitality management or taking hotel management courses online. Whether you’re aiming for resort management or starting in front desk hotel positions, this book is a great guide.
Here’s the link: https://www.amazon.com/dp/B0DZTPBJP8
The book also includes useful dialogues like:
– Hotel reservation conversation in English
– Hotel check-out conversation in English
– Hotel guest complaints English conversation
– Hotel room service English conversation
It’s ideal for those preparing for hotel receptionist jobs, improving hotel customer service, or understanding hotel standard operating procedures. A perfect resource if you’re pursuing a hotel management degree or looking into hotel front desk careers.
Once again, thank you for the article. This was very well done.
Loved the way you explained it. As a hotel receptionist myself, this article really caught my attention.
For anyone interested in hotel guest services, hotel booking process, or learning more about hotel front office operations and customer service, I highly recommend a helpful book I found recently on Amazon. It’s full of practical hotel English conversation examples, hotel receptionist English phrases, and hotel check-in dialogue in English that are useful for both beginners and professionals.
It’s especially helpful for those studying a bachelor of hospitality management or taking hotel management courses online. Whether you’re aiming for resort management or starting in front desk hotel positions, this book is a great guide.
Here’s the link: https://www.amazon.com/dp/B0DZTPBJP8
The book also includes useful dialogues like:
– Hotel reservation conversation in English
– Hotel check-out conversation in English
– Hotel guest complaints English conversation
– Hotel room service English conversation
It’s ideal for those preparing for hotel receptionist jobs, improving hotel customer service, or understanding hotel standard operating procedures. A perfect resource if you’re pursuing a hotel management degree or looking into hotel front desk careers.
Once again, thank you for the article. Looking forward to your next post.